- Home
- MGRM vs ADAG Comparison
MGRM vs ADAG Comparison
Compare MGRM & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- ADAG
- Stock Information
- Founded
- MGRM 2016
- ADAG 2011
- Country
- MGRM United States
- ADAG China
- Employees
- MGRM N/A
- ADAG N/A
- Industry
- MGRM Medical/Dental Instruments
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- MGRM Health Care
- ADAG Health Care
- Exchange
- MGRM Nasdaq
- ADAG Nasdaq
- Market Cap
- MGRM 79.9M
- ADAG 91.4M
- IPO Year
- MGRM N/A
- ADAG 2021
- Fundamental
- Price
- MGRM $2.91
- ADAG $1.88
- Analyst Decision
- MGRM Strong Buy
- ADAG Strong Buy
- Analyst Count
- MGRM 1
- ADAG 1
- Target Price
- MGRM $5.40
- ADAG $8.00
- AVG Volume (30 Days)
- MGRM 49.7K
- ADAG 92.2K
- Earning Date
- MGRM 08-13-2025
- ADAG 07-24-2025
- Dividend Yield
- MGRM N/A
- ADAG N/A
- EPS Growth
- MGRM N/A
- ADAG N/A
- EPS
- MGRM N/A
- ADAG N/A
- Revenue
- MGRM N/A
- ADAG $103,204.00
- Revenue This Year
- MGRM N/A
- ADAG $6,488.89
- Revenue Next Year
- MGRM N/A
- ADAG $57.50
- P/E Ratio
- MGRM N/A
- ADAG N/A
- Revenue Growth
- MGRM N/A
- ADAG N/A
- 52 Week Low
- MGRM $1.92
- ADAG $1.33
- 52 Week High
- MGRM $4.21
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- MGRM 62.99
- ADAG 44.87
- Support Level
- MGRM $2.81
- ADAG $1.74
- Resistance Level
- MGRM $2.99
- ADAG $2.10
- Average True Range (ATR)
- MGRM 0.12
- ADAG 0.10
- MACD
- MGRM 0.01
- ADAG -0.02
- Stochastic Oscillator
- MGRM 80.61
- ADAG 16.67
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.